Insiders · Profile

Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine. Filing since 25 Jul 2024. CIK 0001985604

Company

Date

Role

Action

Shares

Amount

Of holding

EDIT Editas Medicine, Inc.

3 Sep 2026

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

709

$2.15K

1.1%

EDIT Editas Medicine, Inc.

28 Jul 2026

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

4,928

$13.16K

7.3%

EDIT Editas Medicine, Inc.

3 Jun 2026

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

731

$1.97K

1.1%

EDIT Editas Medicine, Inc.

3 Mar 2026

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

749

$1.51K

1.1%

EDIT Editas Medicine, Inc.

3 Dec 2025

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

713

$1.54K

1.0%

EDIT Editas Medicine, Inc.

3 Sep 2025

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

710

$1.84K

1.0%

EDIT Editas Medicine, Inc.

31 Jul 2025

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

5,121

$12.76K

7.4%

EDIT Editas Medicine, Inc.

3 Jun 2025

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

726

$1.25K

1.0%

EDIT Editas Medicine, Inc.

4 Mar 2025

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

2,891

$4.95K

4.0%

EDIT Editas Medicine, Inc.

25 Jul 2024

EVP, CHIEF SCIENTIFIC OFFICER

Sold on a plan

11,886

$64.37K

14.0%

10 decisions on file.